ESEnas Kamal Abdalaziz Seyed

Enas Kamal Abdalaziz Seyed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Enas Kamal Abdalaziz Seyed has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transcranial alternating current stimulation for major depressive disorder: An updated systematic review and meta-analysis of randomized trials with GRADE assessment

    by Yehia Nabil, Khaled Abdalla Moghib, Zeyad Tarek, Zeinab Helmy, Nourhan Hatem, Abd El-Hai Ahmed Mansour, Boyuan Lu, Mohamed Ahmed Ali, Yazan Mohammad Hannoun, Hossam Mohamed Abdelzaher, et al.

  • Open Access

    Magnesium sulfate versus dexmedetomidine as adjuvants for peribulbar block: a GRADE-assessed systematic review and meta-analysis

    by Fahad Amin, Moazam Ali, Tarooba Khan, Muhammad Shoaib Bilal, Roshan Zahra, Hamza Sajid, Syed Zakria Ali Shah, Sanjeet Kumar, Saqib Rehman, Momna Ubaidullah, et al.

  • Open Access

    Melatonin supplementation in multiple sclerosis: a systematic review of clinical, imaging, biomarker, and safety outcomes

    by Yehia Nabil, Alina Ghazou, Sara Abodabesh, Anas Mansour, Ahmed Adel Mohamed, Salma Allam, Nourhan Eid, Yara Ibrahim Wahba, Ragda Mamoun MohamedAhmed Mamoun, Aya Samy, et al.

    Purpose: Melatonin may act on immune, oxidative, and circadian pathways relevant to multiple sclerosis (MS), yet its clinical benefits and safety profile remain unclear. This systematic review assessed the efficacy and safety of oral melatonin supplementation in adults with MS. Methods: We searched MEDLINE (via PubMed), Scopus, Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception through August 15, 2026, and included randomized and prospective non-randomized intervention studies. Two reviewers independently selected studies, extracted data, and assessed risk of bias using RoB 2 or ROBINS-I. Given substantial clinical and methodological heterogeneity, we synthesized findings without meta-analysis, following SWiM guidance, and rated certainty of evidence with GRADE. We registered the protocol in PROSPERO (CRD420251167112). Results: We included 10 independent studies, reported across 17 publications, covering 435 participants. Nine were randomized trials (two of them crossover designs), and one was a prospective non-randomized intervention study. Melatonin doses spanned 0.5–300 mg/day, with treatment durations from 2 weeks to 14 months. The evidence did not show reductions in relapse activity, disability progression, or new MRI activity. Small studies suggested possible improvements in sleep, fatigue, pain, physical function, cognition, mood, autonomic function, body composition, and inflammatory, metabolic, or oxidative-stress biomarkers, but these results were inconsistent and rarely replicated. Doses of 0.5–25 mg/day were generally well tolerated, though some participants discontinued treatment and adverse-event reporting remained incomplete. At 300 mg/day, three of four melatonin-treated participants developed hypertransaminasemia, which resolved after withdrawal and recurred on rechallenge in one case. Certainty of evidence was low or very low for every outcome assessed. Conclusion: Current evidence does not support a disease-modifying effect of melatonin in MS. Any symptomatic or biomarker benefits need confirmation in larger, well-designed trials, and high-dose melatonin may carry meaningful hepatic risk.

  • One target, two evidence streams: Rituximab versus ocrelizumab in relapsing multiple sclerosis: A design-stratified systematic review, meta-analysis, and concordance assessment

    by Yehia Nabil, Ahmed Shaheen, Anas Mansour, Enas Kamal Abdalaziz Seyed, Baraah abu Alsel, Safya E. Esmaeel, Mostafa Meshref, Ram Saha

  • Open Access

    Primary hyperparathyroidism in a 14-year-old female presenting with acute pancreatitis: case report and review of the literature

    by Lara Hamzeh Hamzeh, Ursula Abu Nahla, Enas Kamal Abdalaziz Seyed, Elsayed S. Moubarak, Mena Ayman Elgendy

  • Open Access

    Acute Myeloid Leukemia in a Patient With Xeroderma Pigmentosum: A Case Report

    by Mina Soryal, Mohamed Mahmoud Marey, Malak A. Hassan, Rawan El‐Sayed, Enas Kamal Abdalaziz Seyed, Ashraf Elghandour

    Acute myeloid leukemia may occur in patients with xeroderma pigmentosum at a younger age and can be associated with complex cytogenetics and poor treatment response, highlighting the importance of regular hematologic monitoring.


  • Open Access

    Impact of War on Burnout among Medical Students at Al-Neelain University in Sudan, 2024

    by Enas Seyed, Mohammed Yhya, Ruaa El.WAlid, Assma Gamie, Noha Sofyan

    Background: Burnout, characterized by emotional exhaustion, depersonalization, and a reduced sense of personal accomplishment, is relatively frequent among medical students due to the demanding nature of medical education. In conflict zones, such as Sudan, the challenges are exacerbated by war, which disrupts training and increases psychological stress. Despite its potential long-term consequences on individuals and healthcare systems, burnout among medical students in these settings remains underexplored. Aim: This study aimed to assess the prevalence of burnout among medical students at Al-Neelain University in Sudan, with a focus on the impact of war on burnout levels. Additionally, it evaluated the students' coping mechanisms and resilience in overcoming the challenges posed by conflict and academic disruptions. Methods: A cross-sectional study was conducted among 259 medical students at Al-Neelain University, selected using a stratified sampling technique. Data were collected through an online, close-ended questionnaire comprising three sections: sociodemographic and training-related questions, a burnout assessment using the Maslach Burnout Inventory-Student Survey (MBI-SS), and an evaluation of resilience using the Brief Resilient Coping Scale (BRCS). The data collected were analyzed using Microsoft Excel and the Statistical Package for the Social Sciences (SPSS). Results: Of the total of 259 medical students at Al-Neelain University, the prevalence of burnout using the two-dimensional definition was 18.5%, while 8.1% met the criteria for three-dimensional burnout. High emotional exhaustion and cynicism were observed in 31.7% and 32.8% of students, respectively, whereas 30.1% had low academic efficacy. Burnout was significantly associated with poor academic performance, inadequate social support, and limited internet access (p < 0.001). The Brief Resilient Coping Scale (BRCS) showed that only 19.3% of students had high resilience coping, while 45.9% had low resilience coping. Resilience showed a statistically significant moderate positive correlation with academic efficacy (r = 0.487, p < 0.001) and a weak negative correlation with cynicism (r = -0.226, p < 0.001). While burnout had a limited direct impact on clinical training for fifth-year students, conflict-related disruptions, such as reduced access to hospitals and inconsistent mentorship, posed significant challenges to their educational experiences. Conclusion: Medical students at Al-Neelain University exhibited an alarming prevalence of burnout, compounded by academic and conflict-related challenges. It demonstrated the urgent need for interventions to reduce burnout, enhance resilience, and improve resource access, which are essential to support students' well-being and ensure training continuity, especially in conflict zones like Sudan. Table 1. Prevalence of Burnout, sub-scales, levels among medical students at Al-Neelain University (n=259). Frequency (n) Percent (%) Emotional Exhaustion (High) 82 31.70% Cynicism (High) 85 32.80%